Proposed minimum information guideline for kidney disease—research and clinical data reporting: a cross-sectional study

Kumuthini, Judit, van Woerden, Christiaan, Mallett, Andrew, Zass, Lyndon, Chaouch, Melek, Thompson, Michael, Johnston, Katherine, Mbiyavanga, Mamana, Baichoo, Shakuntala, Mungloo-Dilmohamud, Zahra, Patel, Chirag, and Mulder, Nicola (2019) Proposed minimum information guideline for kidney disease—research and clinical data reporting: a cross-sectional study. BMJ Open, 9 (11). e029539.

[img]
Preview
PDF (Published Version) - Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (500kB) | Preview
View at Publisher Website: https://doi.org/10.1136/bmjopen-2019-029...
 
27


Abstract

Objective This project aimed to develop and propose a standardised reporting guideline for kidney disease research and clinical data reporting, in order to improve kidney disease data quality and integrity, and combat challenges associated with the management and challenges of ‘Big Data’.

Methods A list of recommendations was proposed for the reporting guideline based on the systematic review and consolidation of previously published data collection and reporting standards, including PhenX measures and Minimal Information about a Proteomics Experiment (MIAPE). Thereafter, these recommendations were reviewed by domain-specialists using an online survey, developed in Research Electronic Data Capture (REDCap). Following interpretation and consolidation of the survey results, the recommendations were mapped to existing ontologies using Zooma, Ontology Lookup Service and the Bioportal search engine. Additionally, an associated eXtensible Markup Language schema was created for the REDCap implementation to increase user friendliness and adoption.

Results The online survey was completed by 53 respondents; the majority of respondents were dual clinician-researchers (57%), based in Australia (35%), Africa (33%) and North America (22%). Data elements within the reporting standard were identified as participant-level, study-level and experiment-level information, further subdivided into essential or optional information.

Conclusion The reporting guideline is readily employable for kidney disease research projects, and also adaptable for clinical utility. The adoption of the reporting guideline in kidney disease research can increase data quality and the value for long-term preservation, ensuring researchers gain the maximum benefit from their collected and generated data.

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial.

Item ID: 67869
Item Type: Article (Research - C1)
ISSN: 2044-605
Copyright Information: © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ
Funders: National Health and Medical Research Council of Australia (NHMRC)
Projects and Grants: NHMRC APP1113531
Date Deposited: 16 Sep 2021 01:36
FoR Codes: 32 BIOMEDICAL AND CLINICAL SCIENCES > 3202 Clinical sciences > 320214 Nephrology and urology @ 100%
SEO Codes: 20 HEALTH > 2001 Clinical health > 200199 Clinical health not elsewhere classified @ 100%
Downloads: Total: 27
Last 12 Months: 12
More Statistics

Actions (Repository Staff Only)

Item Control Page Item Control Page